Elevance Health Insiders Sell US$6.7m Of Stock, Possibly Signalling Caution

Sat, Aug 2, 2025, 8:00 AM 3 min read

Many Elevance Health, Inc. (NYSE:ELV) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

The Executive VP & President of Commercial Health Benefits, Charles Kendrick, made the biggest insider sale in the last 12 months. That single transaction was for US$3.2m worth of shares at a price of US$432 each. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. The silver lining is that this sell-down took place above the latest price (US$275). So it is hard to draw any strong conclusion from it.

In total, Elevance Health insiders sold more than they bought over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

View our latest analysis for Elevance Health

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

It's good to see that Elevance Health insiders have made notable investments in the company's shares. Specifically, President Gail Boudreaux bought US$2.4m worth of shares in that time, and we didn't record any sales whatsoever. That shows some optimism about the company's future.

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. Elevance Health insiders own about US$77m worth of shares. That equates to 0.1% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.